Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply
Resilience and Lilly expand strategic partnership first established in 2023 Investment will significantly increase U.S. production of Lilly’s...
NEWS
Read on
Resilience and JobsOhio Announce Continued Partnership and Expansion in Blue Ash
San Diego, CA & Cincinnati, OH – March 26, 2025 – National Resilience, Inc. (Resilience), a technology-focused biomanufacturing company dedicated to...
Resilience Expands Clinical and Commercial Drug Product Manufacturing Capabilities and Capacities
$225 million to be invested into Cincinnati facility to increase PFS and Cartridge fill/finish capabilities Expanding Research Triangle Park (RTP)...
National Resilience and Taiwan Bio-Manufacturing Corporation Announce Groundbreaking Partnership in Biomanufacturing Innovation
Taipei, Taiwan and San Diego, California, February 5, 2024 – National Resilience, Inc. (Resilience), a technology-focused biomanufacturing company...
Resilience Announces Expansion in West Chester
Project will create 440 new jobs and include further development of Resilience’s West Chester biomanufacturing site
Resilience Appoints Bill Marth as President of Services
National Resilience, Inc. (Resilience), a technology-focused biomanufacturing company dedicated to broadening access to complex medicines, today...
